Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05531461 · ClinicalTrials.gov registry record
Cognition and Imaging With Tigertriever
A clinical trial of Stroke, sponsored by Rapid Medical.
- Recruiting
- Registry status
- 424
- Enrollment target
- 3
- Study locations
NCT05531461: Recruiting study of Stroke, sponsored by Rapid Medical.
NCT05531461 is a study of Stroke that is actively recruiting participants, run by Rapid Medical. The registered enrollment target is 424 participants, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05531461, a study of Stroke, is actively recruiting participants, sponsored by Rapid Medical.
- RECRUITING
- Registry status
- 424 participants
- Enrollment target
- 3
- Study locations
Study Summary
The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.
Primary Outcome
\*successful reperfusion is defined as eTICI ≥2b50 with the Tigertriever device. * Cognitive benefit is defined as change in Montreal Cognitive Assessment (MoCA) of 1.5 Standard Deviations (SD) from 4 days post treatment (or discharge if earlier) and 180 days post treatment; or MoCA ≥26 at 180 days post treatment.
Conditions Studied
Study Locations (3)
California
- University of California - Los Angeles
Michigan
- Corewell Health Research Institute - Grand Rapids
New York
- Westchester Medical Center - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 424 participants |
| Start Date | 2024-10-28 |
| Est. Completion | 2026-11 |
What NCT05531461 shows while recruiting
NCT05531461 is an observational study that tracks outcomes without assigning an intervention. The registered 424 participants enrollment target is mid-sized for trials with a published cap, below the 12,015-participant average among 454 other Stroke trials with a reported enrollment target (96% lower).
The record links to 1 condition, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT05531461 reports a single indexed study location in California, Michigan, New York.
Frequently Asked Questions
What is clinical trial NCT05531461 about?
NCT05531461 is a clinical study titled "Cognition and Imaging With Tigertriever". The objective of the COGNITIVE Study is to evaluate whether successful reperfusion with Tigertriever is associated with cognitive benefit.
What is the current status of trial NCT05531461?
This trial is currently recruiting. The enrollment target is 424 participants. The study started on 2024-10-28. Estimated completion is 2026-11.
What conditions does trial NCT05531461 study?
This clinical trial studies the following conditions: Stroke.
Who is sponsoring clinical trial NCT05531461?
This trial is sponsored by Rapid Medical, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05531461 being conducted?
This trial has 3 study locations across California, Michigan, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05531461's enrollment target sits among peer trials
424 63rd of 454 higher than 392 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05632770 · 424 participants · NA
A Deployment Focused Pragmatic Trial of Optimal Stepped Care Intervention Targeting PTSD and Comorbidity for Acutely Hospitalized Injury Survivors Treated in US Trauma Care Systems
- NCT05733767 · 424 participants · Phase 2
Smoking Cessation Pharmacotherapy-Nurse Practitioner Led Tobacco Treatment Team Study
- NCT06978127 · 424 participants · NA
Technology Assisted Collaborative Care Intervention to Improve Patient-centered Outcomes in Dialysis Patients
- NCT07140913 · 424 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI